Sort
130,381 grants matching “hiv”
Design of inhibitors targeted to the CD4 binding site on HIV - 1gp120
$777,449Asim K Debnath · New York Blood Center · R56 · FY2023 · AI
Integrating PrEP Decision-Making into Contraceptive Counseling in Family Planning Clinics
$777,440Jaimie Meyer · Yale University · R34 · FY2024 · MH
Improving wellbeing, HIV prevention, and intersectional stigma among multiply marginalized Chinese women in NYC
$777,437Sahnah Lim · New York University School Of Medicine · R34 · FY2025 · MH
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment
$777,434Heidi M. Crane · University Of Washington · R01 · FY2017 · HL
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$777,418Tracy M Handel · University Of California, San Diego · U01 · FY2014 · GM
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$777,412Tracy M Handel · University Of California, San Diego · U01 · FY2012 · GM
Commensal microbiome impact on CD4 T cell lymphopenia in HIV-1 infection
$777,412Souheil Antoine Younes · Emory University · R01 · FY2022 · AG
Mechanisms of Persistent Inflammasome Activation in Myeloid Cells
$777,398Suryaram Gummuluru · Boston University Medical Campus · R01 · FY2024 · DA
Epigenetic Reprogramming in HIV-Associated Cardio-Vascular Disease
$777,389Michael Ilya Bukrinsky · George Washington University · R01 · FY2021 · HL
In vivo Evaluation of Safety and Pharmacology of the Sustained Release Formulation of Dolutegravir in Pre-Conception and Early Stages of Pregnancy in Animal Models
$777,388Martina Kovarova · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HD
In vivo Evaluation of Safety and Pharmacology of the Sustained Release Formulation of Dolutegravir in Pre-Conception and Early Stages of Pregnancy in Animal Models
$777,388Martina Kovarova · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HD
In vivo Evaluation of Safety and Pharmacology of the Sustained Release Formulation of Dolutegravir in Pre-Conception and Early Stages of Pregnancy in Animal Models
$777,388Martina Kovarova · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HD
In vivo Evaluation of Safety and Pharmacology of the Sustained Release Formulation of Dolutegravir in Pre-Conception and Early Stages of Pregnancy in Animal Models
$777,388Martina Kovarova · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HD
In vivo Evaluation of Safety and Pharmacology of the Sustained Release Formulation of Dolutegravir in Pre-Conception and Early Stages of Pregnancy in Animal Models
$777,388Martina Kovarova · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HD
Nucleic Acid Footprinting and development of small molecule antagonists
$777,378Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Improving the Organizational Social Context to Address Structural Racism and Discrimination: A Randomized Controlled Trial to Reduce Racial Disparities in Viral Suppression and Retention in HIV Care
$777,377Florence M Momplaisir · University Of Pennsylvania · R01 · FY2024 · NR
The High-Intensity Exercise to Attenuate Limitations and Train Habits (HEALTH) in Older Adults with HIV
$777,338Kristine Mace Erlandson · University Of Colorado Denver · R01 · FY2024 · AG
Defining the molecular mechanism of gut inflammation and barrier dysfunction in people with HIV (PWH)
$777,336Ta-Chiang Liu · Washington University · R01 · FY2025 · DK
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$777,308Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2017 · DA
Targeting tonsillar B cells for the induction of effective mucosal immunity to HIV
$777,281James J Kobie · University Of Alabama At Birmingham · R01 · FY2020 · DE
Administrative Core
$777,219Chloe L Thio · Johns Hopkins University · U19 · FY2025 · AI
Identifying TB transmitters in high TB/HIV burdened communities
$777,199Robin Wood · Desmond Tutu Hiv Foundation · R01 · FY2021 · AI
Identifying TB transmitters in high TB/HIV burdened communities
$777,199Robin Wood · Desmond Tutu Hiv Foundation · R01 · FY2022 · AI
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use
$777,196Amy Caroline Justice · Yale University · U24 · FY2011 · AA
ACTION: Study of ACuTe Infections On Novel HIV Prevention Modalities
$777,152Catherine Anne Stimets Koss · University Of California, San Francisco · R01 · FY2023 · AI